Search research articles
Contact Us
Filters
Showing results (141-150 of 203) with videos related to
Page
of 21
Sort By:
Cancer Treatment and Research Communications
|
July 24, 2020
Circulating-tumor DNA as predictor of enzalutamide response post-abiraterone treatment in metastatic castration-resistant prostate cancer
Marcus Moses, Alex Niu, Michael B Lilly, et al.
European Urology
|
December 5, 2024
Novel Methods to Assess Tumor Burden and Minimal Residual Disease in Genitourinary Cancers
Pedro C Barata, Kevin K Zarrabi, Axel Bex, et al.
Clinical Genitourinary Cancer
|
September 3, 2018
Effect of Switching Systemic Treatment After Stereotactic Radiosurgery for Oligoprogressive, Metastatic Renal Cell Carcinoma
Pedro C Barata, Prateek Mendiratta, Rupesh Kotecha, et al.
The Oncologist
|
October 7, 2025
Molecular and clinical correlates of high FOLH1 (PSMA) RNA expression in primary and metastatic prostate cancer
Rana R McKay, Shayan S Nazari, Andrew Elliott, et al.
Cancers
|
December 23, 2023
The Genomic Landscape of Urothelial Carcinoma with High and Low <i>ERBB2</i> Expression
Agreen Hadadi, Harris B Krause, Andrew Elliott, et al.
Translational Andrology and Urology
|
May 21, 2026
Variant allele frequency as a potential marker in response to frontline systemic therapy for patients with locally advanced and metastatic urothelial carcinoma
Albert Jang, Sulin Wu, Hamsa L S Kumar, et al.
Cancers
|
April 26, 2025
The Influence of the Germline <i>HSD3B1</i> Adrenal-Permissive Allele (c.1100 C) on the Somatic Alteration Landscape, the Transcriptome, and Immune Cell Infiltration in Prostate Cancer
Samuel Kellen, Allison Makovec, Carly D Miller, et al.
Targeted Oncology
|
April 7, 2018
Atezolizumab in Metastatic Urothelial Carcinoma Outside Clinical Trials: Focus on Efficacy, Safety, and Response to Subsequent Therapies
Pedro C Barata, Dhrmesh Gopalakrishnan, Vadim S Koshkin, et al.
JAMA Network Open
|
August 6, 2024
Adjuvant Everolimus in Non-Clear Cell Renal Cell Carcinoma: A Secondary Analysis of a Randomized Clinical Trial
Shuchi Gulati, Catherine Tangen, Christopher W Ryan, et al.
Cancer
|
August 11, 2023
Comprehensive genomic profiling of penile squamous cell carcinoma and the impact of human papillomavirus status on immune-checkpoint inhibitor-related biomarkers
Bassel Nazha, Tony Zhuang, Sharon Wu, et al.
Page
of 21
Search research articles
Search
Showing results (141-150 of 203) with videos related to
Sort By:
Page
of 21
Cancer Treatment and Research Communications
|
July 24, 2020
Circulating-tumor DNA as predictor of enzalutamide response post-abiraterone treatment in metastatic castration-resistant prostate cancer
Marcus Moses, Alex Niu, Michael B Lilly, et al.
European Urology
|
December 5, 2024
Novel Methods to Assess Tumor Burden and Minimal Residual Disease in Genitourinary Cancers
Pedro C Barata, Kevin K Zarrabi, Axel Bex, et al.
Clinical Genitourinary Cancer
|
September 3, 2018
Effect of Switching Systemic Treatment After Stereotactic Radiosurgery for Oligoprogressive, Metastatic Renal Cell Carcinoma
Pedro C Barata, Prateek Mendiratta, Rupesh Kotecha, et al.
The Oncologist
|
October 7, 2025
Molecular and clinical correlates of high FOLH1 (PSMA) RNA expression in primary and metastatic prostate cancer
Rana R McKay, Shayan S Nazari, Andrew Elliott, et al.
Cancers
|
December 23, 2023
The Genomic Landscape of Urothelial Carcinoma with High and Low <i>ERBB2</i> Expression
Agreen Hadadi, Harris B Krause, Andrew Elliott, et al.
Translational Andrology and Urology
|
May 21, 2026
Variant allele frequency as a potential marker in response to frontline systemic therapy for patients with locally advanced and metastatic urothelial carcinoma
Albert Jang, Sulin Wu, Hamsa L S Kumar, et al.
Cancers
|
April 26, 2025
The Influence of the Germline <i>HSD3B1</i> Adrenal-Permissive Allele (c.1100 C) on the Somatic Alteration Landscape, the Transcriptome, and Immune Cell Infiltration in Prostate Cancer
Samuel Kellen, Allison Makovec, Carly D Miller, et al.
Targeted Oncology
|
April 7, 2018
Atezolizumab in Metastatic Urothelial Carcinoma Outside Clinical Trials: Focus on Efficacy, Safety, and Response to Subsequent Therapies
Pedro C Barata, Dhrmesh Gopalakrishnan, Vadim S Koshkin, et al.
JAMA Network Open
|
August 6, 2024
Adjuvant Everolimus in Non-Clear Cell Renal Cell Carcinoma: A Secondary Analysis of a Randomized Clinical Trial
Shuchi Gulati, Catherine Tangen, Christopher W Ryan, et al.
Cancer
|
August 11, 2023
Comprehensive genomic profiling of penile squamous cell carcinoma and the impact of human papillomavirus status on immune-checkpoint inhibitor-related biomarkers
Bassel Nazha, Tony Zhuang, Sharon Wu, et al.
Page
of 21